OSTEO-PHARMA

osteo-pharma-logo

Osteo-Pharma BV develops novel medication and medical devices for orthopedic and dental applications for the local treatment of bone fractures and bone defects. Osteo-Pharma’s technology platform is based on applying local sustained delivery of low molecular weight compounds that enhance bone formation while simultaneously inhibiting bone resorption. Osteo-Pharma was founded in June 2014 and applies novel technology to deliver pharmaceuticals locally near to a bone fracture or bone defect. By ... encapsulating pharmaceuticals in a biodegradable carrier sustained release of pharmaceuticals over a 6-8 week period is achieved. During this period bone growth is enhanced and bone resorption is inhibited resulting in a net effect of bone growth. This technology is now in development to improve the healing of bone fractures, bone defects and for the treatment of osteoarthritis. In addition, Osteo-Pharma is developing a novel coating for dental and orthopedic implants to improve osseo-integration and to prevent implant loosening.

#SimilarOrganizations #People #Website #More

OSTEO-PHARMA

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2014-01-01

Address:
Oss, Noord-Brabant, The Netherlands

Country:
The Netherlands

Website Url:
http://www.osteo-pharma.com

Total Employee:
1+

Status:
Active

Contact:
+31 (0)85 025 0021

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Mobile Non Scaleable Content Google Maps WordPress 5.8


Similar Organizations

actigenomics-logo

Actigenomics

Actigenomics is a biotechnology company.

signature-bioscience-logo

Signature BioScience

Biotech company creating a drug-screening technology platform

Current Employees Featured

jan-gossen_image

Jan Gossen
Jan Gossen CEO and founder @ Osteo-Pharma
CEO and founder

Official Site Inspections

http://www.osteo-pharma.com Semrush global rank: 5.14 M Semrush visits lastest month: 1.57 K

  • Host name: s195.webhostingserver.nl
  • IP address: 141.138.168.151
  • Location: Netherlands
  • Latitude: 52.3824
  • Longitude: 4.8995
  • Timezone: Europe/Amsterdam

Loading ...

More informations about "Osteo-Pharma"

COMPANY | Osteo-Pharma

Osteo-Pharma BV develops novel medications and medical devices for orthopedic and dental applications and for the local treatment of bone disorders. Osteo-Pharma’s technology …See details»

Osteo-Pharma - Crunchbase Company Profile & Funding

Osteo-Pharma BV develops novel medication and medical devices for orthopedic and dental applications for the local treatment of bone fractures and bone defects. Osteo-Pharma’s …See details»

Osteo-Pharma - 2025 Company Profile - Tracxn

Apr 28, 2025 Osteo-Pharma is a Dutch early-stage biotech developing drug-device combos for healing Bone fractures. The company is making proprietary formulations by encapsulating the …See details»

Osteo-Pharma BV - CMOCRO

Osteo-Pharma BV develops novel medications and medical devices for orthopedic and dental applications and for the local treatment of bone disorders. Osteo-Pharma’s technology …See details»

Osteo-Pharma - Overview, News & Competitors | ZoomInfo.com

Osteo-Pharma is a Life Sciences company focused on the development of local treatments to improve the healing of bone fracture and defects. It's proprietary OsteoActivator platform is …See details»

Osteo-Pharma BV - Drug pipelines, Patents, Clinical trials - Synapse

Sep 1, 2024 Explore Osteo-Pharma BV with its drug pipeline, therapeutic area, technology platform, 2 literature.See details»

Osteo-Pharma | Bone Therapeutics

Osteo-Pharma BV was founded in 2014 and develops novel products for orthopedic and dental applications for the local treatment of bone fractures and bone defects.See details»

Osteo-Pharma and Emultech Announce Joint Venture to Develop …

Nov 17, 2021 About Osteo-Pharma Osteo-Pharma is a Life Sciences company developing novel medical devices and pharmaceuticals to improve the local healing of bone defects and …See details»

Osteo-Pharma - Contacts, Employees, Board Members

Osteo-Pharma is a technology platformWe're working on getting contact data for Osteo-PharmaSee details»

MANAGEMENT - Osteo-Pharma

During 2011-2012 he has been Therapeutic Area Head Oncology (ad interim) at Amgen BV where he was involved in the market introduction of Xgeva for treatment of osteoporosis and bone …See details»

Osteo-Pharma - Overview, News & Competitors | ZoomInfo.com

Osteo-Pharma is a Life Sciences company focused on the development of local treatments to improve the healing of bone fracture and defects. It's proprietary OsteoActivator platform is …See details»

SCIENTIFIC ADVISORY BOARD | Osteo-Pharma

Osteo-Pharma announces Scientific Advisory Board Osteo-Pharma, a Dutch Life Sciences company developing novel pharmaceuticals and medical devices to improve the local healing …See details»

About - Osteo-Pharma

This is an example of a WordPress page, you could edit this to put information about yourself or your site so readers know where you are coming from. You can create as many pages like this …See details»

Osteo-Pharma announces Scientific Advisory Board

Osteo-Pharma, a Dutch Life Sciences company developing novel pharmaceuticals and medical devices to improve the local healing of bone fractures and defects, announced its Scientific …See details»

BT-002 (Osteo Pharma) - Drug Targets, Indications, Patents

May 7, 2025 BT-002(Osteo Pharma), Initially developed by Osteo-Pharma BV, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Skin and …See details»

Osteo-Pharma BV (骨骼藥品責任有限公司): 药物管线,专利,临床 …

了解Osteo-Pharma BV (骨骼藥品責任有限公司)公司的药物管线,治疗领域,技术平台,以及它的1项临床试。See details»

Osteo-Pharma and Emultech Announce Joint Venture to Develop …

Nov 17, 2021 About Osteo-Pharma Osteo-Pharma is a Life Sciences company developing novel medical devices and pharmaceuticals to improve the local healing of bone defects and fractures.See details»

Osteo-Pharma Receives MREC Approval for Initiation of Clinical Trial

May 13, 2021 Osteo-Pharma announced that it has successfully obtained MREC approval for testing their lead product, OsteoActivator-P, in patients. OsteoActivator-P is a novel coated …See details»

Osteo-Pharma product pipeline

Osteo-Pharma product pipeline Osteo-Pharma’s develops products with the novel OsteoActivatorTM technology for many different applications. OsteoActivator-P / …See details»

Osteo-Pharma and Emultech Announce Joint Venture to Develop …

Nov 19, 2021 Emultech and Osteo-Pharma today announced a joint venture, Bone-Tech, to develop what could be the first disease-modifying treatment for osteoarthritis of the knee.See details»

linkstock.net © 2022. All rights reserved